Regions
KKR-backed massage chair business files for Hong Kong IPO
V3 Brands Asia, a KKR-backed holding entity for OSIM, which claims to be Asia’s number one brand in the premium massage chairs market, has filed for an IPO in Hong Kong.
CDH CEO leads Hong Kong SPAC
Shuge Jiao, CEO of CDH Investments, is chairing a Hong Kong special purpose acquisition company (SPAC) sponsored by one of the China-based private equity firm’s portfolio companies.
Tiger Global, Coatue lead Series B for Singapore's AI Rudder
Tiger Global Management and Coatue Management have led a USD 50m Series B round for Singapore-based voice artificial intelligence start-up AI Rudder.
China's Pony.ai hits $8.5b valuation with Series D
Chinese autonomous driving technology supplier Pony.ai has closed the first tranche of a Series D round at a valuation of USD 8.5bn. This represents a 65% increase from the Series C.
Warburg Pincus buys control of Indonesian insurer
Warburg Pincus has acquired stakes in two Indonesian insurance businesses from Spain-headquartered multinational insurance company Mapfre for EUR 56.6m (USD 62.9m).
Dymon pursues take-private of Singapore healthcare business
Dymon Asia Private Equity has made a take-private offer for Singapore-listed healthcare services provider Singapore O&G that values the company at approximately SGD 141m (USD 103.3m).
AVCJ Awards 2021: Deal of the Year – Mid Cap: Danggeun Market
A social, hyperlocal overlay has made Korea’s Danggeun Market a subversively complex e-commerce play. As the company scales and experiments, it reflects new confidence in its home market
AVCJ Awards 2021: Responsible Investment: The Arnott’s Group
In taking ownership of an iconic Australian brand like Tim Tam, KKR was conscious of the need to be a market leader on sustainability. Progress is being made across sourcing, emissions, and packaging
US regulations: Coming to Asia
Newly proposed rules for private equity fundraising and reporting in the US are set to be applicable to any manager in Asia that raises US capital. Investors should be alert but not alarmed
Deal focus: Inspiration snares rare China mid-cap tech buyout
Antute, a third-party IT maintenance provider, became an orphan asset following a larger M&A deal. Inspiration Capital Partners sees it as an attractive play on China’s digitalisation drive
Portfolio: Aspirant Group and Yamato Group
Improving cost controls and realising efficiencies underpinned Aspirant Group’s investment thesis for Japanese fish retailer Yamato Group, and they have helped the company withstand external pressures
Deal focus: Faux fowl fast-forwards
Next Gen Foods is pushing hard to popularise its meatless chicken brand Tindle in the name of climate action. The largest-ever Series A round in alternative protein is jumpstarting the campaign
Deal focus: Nexus Point doubles down on dentistry
With a dentist clinic chain already in the portfolio, Nexus Point Capital has backed a B2B procurement platform that services clinics. It is a firm believer in the industry’s tailwinds
Deal focus: Freemium works for Dianxiaomi
China cross-border e-commerce services platform Dianxiaomi has achieved traction, and profitability, by only charging for value-added services. Its Series C will fuel global expansion
China cancer drug developer InxMed raises $50m
InxMed, a China-based biotech company focused on oncology treatments, has raised a USD 50m Series B round led by SDIC China Merchants Investment.
Australia's AGL rejects Brookfield, Grok Ventures bid
Australia-based utility AGL Energy has rebuffed another acquisition attempt from Brookfield Asset Management and Grok Ventures, a private investment firm established by Mike Cannon-Brookes, co-founder of Atlassian.
India's CredAvenue sees 3x valuation jump in six months
Indian small business credit platform CredAvenue has raised a USD 137m round featuring B Capital Group at a valuation of USD 1.3b, up 3x in the past six months.
Korean GP Credian sponsors $200m US SPAC offering
Seoul-based private equity firm Credian Partners has teamed up with CrystalBioSciences, a captive VC unit of biopharmaceutical company CrystalGenomics, to raise USD 200m for a US-listed special purpose acquisition company (SPAC).
HarbourVest closes latest fund-of-funds at $1.6b
HarbourVest Partners has closed its latest flagship private equity fund-of-funds, which will target Asia Pacific and Europe, at USD 1.6bn, beating a target of USD 1.25bn.
Creador makes second SE Asia food investment in five months
Malaysia-based Creador has acquired a significant minority stake in local food industry supplier Custom Food Ingredients for an undisclosed sum as part of a category platform play.
Accel raises $650m for seventh India fund
Accel Partners has raised USD 650m for its seventh India VC fund, which will also make early-stage investments in Southeast Asia. The firm’s total assets under management in the region now top USD 2bn.
BGH seeks regulatory action amid battle for Australia's Virtus
BGH Capital has asked Australia’s Takeovers Panel to intervene a second time in its pursuit of Virtus Health after the fertility care business resolved to engage with CapVest Partners and not entertain BGH’s improved offer.
China 3D cell culture business secures Series B
CytoNiche, a Beijing-based provider of 3D micro-structure engineering technology used for stem cell research, has raised nearly CNY 300m (USD 47m) in a Series B led by Gaorong Capital and CICC Capital.